ANWESHA DAS

Ms. ANWESHA DAS

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2023 in Life
Verified
Journal Article
Open access
PDF file
Arijit NandiArijit Nandi
Arijit Nandi
ADANWESHA DAS
ANWESHA DAS
YDYadu Nandan Dey
Yadu Nandan Dey
KKKuldeep Kumar
Kuldeep Kumar
The endocannabinoid system consists of several phytocannabinoids, cannabinoid receptors, and enzymes that aid in numerous steps necessary to manifest any pharmacological activity. It is well known that the endocannabinoid system inhibits the pathogenesis of the inflammatory and autoimmune disease rheumatoid arthritis (RA). To the best of our knowledge, no research has been done that explains the network-pharmacology-based anti-rheumatic processes by focusing on the endocannabinoid system. Therefore, the purpose of this study is to further our understanding of the signaling pathways, associated proteins, and genes underlying RA based on the abundant natural endocannabinoids. The knowledge on how the phytocannabinoids in Cannabis sativa affect the endocannabinoid system was gathered from the literature. SwissTarget prediction and BindingDB databases were used to anticipate the targets for the phytocannabinoids. The genes related to RA were retrieved from the DisGeNET and GeneCards databases. Protein–protein interactions (high confidence > 0.7) were carried out with the aid of the string web server and displayed using Cytoscape. The Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathway analysis was used to perform enrichment analyses on the endocannabinoid–RA common targets. ShinyGO 0.76 was used to predict the biological processes listed in the Gene Ontology (GO) classification system. The binding affinity between the ligand and the receptors was precisely understood using molecular docking, induced-fit docking, and a molecular dynamics simulation. The network pharmacology analyses predicted that processes like response to oxygen-containing compounds and peptodyl-amino acid modification are related to the potential mechanisms of treatment for RA. These biological actions are coordinated by cancer, neuroactive ligand–receptor interaction, lipids and atherosclerosis, the calcium signaling pathway, and the Rap1 signaling pathway. According to the results of molecular docking, in the context of RA, phytocannabinoids may bind to important target proteins such PIK3CA, AKT1, MAPK9, PRKCD, BRAF, IGF1R, and NOS3. This entire study predicted the phytocannabinoids’ systemic biological characteristics. Future experimental research is needed, however, to confirm the results so far.

26 April 2023 in Food Chemistry Advances
Verified
Journal Article
Open access
BCBornika Chattaraj
Bornika Chattaraj
Arijit NandiArijit Nandi
Arijit Nandi
ADANWESHA DAS
ANWESHA DAS
ABArun Baidya
Arun Baidya
SMSourav Mahata
Sourav Mahata
YDYadu Nandan Dey
Yadu Nandan Dey

2 May 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
DPDarakhshan Parveen
Darakhshan Parveen
ADANWESHA DAS
ANWESHA DAS
SAShaista Amin
Shaista Amin
MAM. Mumtaz Alam
M. Mumtaz Alam
MAMymoona Akhter
Mymoona Akhter
MSM. Shaquiquzzaman
M. Shaquiquzzaman
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus and dexamethasone is a glucocorticoid widely used for its treatment. Dexamethasone is not used in non-severe cases due to its immunosuppressant action. So, considering this, Estrogen and Estetrol were tested for the treatment of COVID-19 as they all possess a common steroid ring and dislike dexamethasone, they are immunoenhancer. Virtual screening of test ligands was performed through molecular docking, MM-GBSA, simulations, in silico ADMET and drug-likeness prediction to identify their potential to inhibit the effects of SARS-CoV-2. Results showed that test ligands possess drug-like properties and they are safe as drug candidates. The protein-ligand interaction study revealed that they bind with the amino acid residues at the active site of the target proteins and the test ligands possess better binding potential than Dexamethasone. With protein Mpro, Estetrol and Estrogen showed docking score of −7.240 and −5.491 kcal/mol, and with protein ACE2, Estetrol and Estrogen showed docking score of −5.269 and −4.732 kcal/mol, respectively. Further, MD Simulation was carried out and most of the interactions of molecular docking are preserved during simulation. The prominent interactions that our test ligands showed during MD Simulation are similar to drugs that possess in vitro anticovid activity as shown in recent studies. Hence, our test ligands possessed potential for anticovid activity and they should be further tested through in vitro and in vivo studies for their activity against COVID-19. Communicated by Ramaswamy H. Sarma

29 November 2023 in Results in Chemistry
Verified
Journal Article
Open access
DSDalbir Singh
Dalbir Singh
RPRajiv Patel
Rajiv Patel
AAAmit Aggarwal
Amit Aggarwal
ADANWESHA DAS
ANWESHA DAS
Saurabh SharmaSaurabh Sharma
Saurabh Sharma
Subhash ChanderSubhash Chander
Subhash Chander

24 January 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
BRBhagyashri Rathod
Bhagyashri Rathod
SJSwarali Joshi
Swarali Joshi
SRSiddulu Regu
Siddulu Regu
VKVeera Naga Sai Manikanta Kella
Veera Naga Sai Manikanta Kella
HKHansal Kumar
Hansal Kumar
ASAmit Shard
Amit Shard

22 December 2025 in RSC Advances
Verified
Journal Article
Open access
PDF file
SBSavan S. Bhalodiya
Savan S. Bhalodiya
MPMehul P. Parmar
Mehul P. Parmar
Shana BalachandranShana Balachandran
Shana Balachandran
CPChirag D. Patel
Chirag D. Patel
Arijit NandiArijit Nandi
Arijit Nandi
Prof. Dr. Hitendra M Patel, FRSCProf. Dr. Hitendra M Patel, FRSC
Prof. Dr. Hitendra M Patel, FRSC
A one-pot method was developed for synthesizing pyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidin-5-ones using the recyclable ionic liquid catalyst [BMIM]OAc in ethanol under reflux conditions. This approach achieved high yields (76–95%) across various substrates along with straightforward product isolation and catalyst recyclability. The synthesized compounds 4(a–l) were tested for antimicrobial activity against Gram-positive and Gram-negative bacteria, and fungal strains. Notably, compounds 4c and 4e showed strong antibacterial effects against S. aureus (MIC: 8 µg mL−1), while 4a, 4b, and 4f effectively inhibited E. coli (MIC: 8 µg mL−1). Compound 4l exhibited notable antifungal activity against C. albicans (MIC: 8 µg mL−1), outperforming the standard drugs. Cytotoxicity assessment on HEK293 cells revealed low toxicity in most derivatives (IC50 > 50 µM), with halogenated analogs (4c, 4e) displaying moderate activity but remaining less toxic than doxorubicin. Molecular docking and dynamics simulations confirmed stable interactions of key compounds (4c, 4e, 4f) with bacterial Tet repressor class D and fungal sterol 14-α demethylase, consistent with experimental data. Overall, this ionic liquid-catalyzed approach provides an efficient route to bioactive heterocycles with promising antimicrobial and anticancer potential.